Ashton Thomas Private Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.36M | Buy |
56,570
+3,746
| +7% | +$98K | 0.03% | 478 |
|
|
2026
Q1 | $1.48M | Buy |
52,824
+2,646
| +5% | +$70.4K | 0.04% | 432 |
|
|
2025
Q4 | $1.25M | Sell |
50,178
-1,050
| -2% | -$26.5K | 0.03% | 427 |
|
|
2025
Q3 | $1.31M | Buy |
51,228
+5,761
| +13% | +$142K | 0.03% | 407 |
|
|
2025
Q2 | $1.1M | Sell |
45,467
-2,980
| -6% | -$69.5K | 0.04% | 394 |
|
|
2025
Q1 | $1.23M | Buy |
48,447
+2,514
| +5% | +$65.8K | 0.05% | 334 |
|
|
2024
Q4 | $1.22M | Sell |
45,933
-12,025
| -21% | -$326K | 0.05% | 347 |
|
|
2024
Q3 | $1.68M | Sell |
57,958
-25,833
| -31% | -$754K | 0.09% | 239 |
|
|
2024
Q2 | $2.34M | Sell |
83,791
-19,369
| -19% | -$533K | 0.13% | 178 |
|
|
2024
Q1 | $2.86M | Sell |
103,160
-7,863
| -7% | -$218K | 0.16% | 157 |
|
|
2023
Q4 | $3.2M | Sell |
111,023
-36,722
| -25% | -$1.11M | 0.2% | 139 |
|
|
2023
Q3 | $4.9M | Buy |
147,745
+11,252
| +8% | +$398K | 0.36% | 72 |
|
|
2023
Q2 | $5.01M | Buy |
136,493
+23,075
| +20% | +$898K | 0.38% | 68 |
|
|
2023
Q1 | $4.63M | Buy |
113,418
+2,290
| +2% | +$98.9K | 0.41% | 63 |
|
|
2022
Q4 | $5.69M | Sell |
111,128
-8,660
| -7% | -$415K | 0.57% | 44 |
|
|
2022
Q3 | $5.24M | Buy |
119,788
+18,196
| +18% | +$884K | 0.59% | 34 |
|
|
2022
Q2 | $5.33M | Buy |
101,592
+4,099
| +4% | +$209K | 0.58% | 39 |
|
|
2022
Q1 | $5.05M | Buy |
97,493
+31,604
| +48% | +$1.64M | 0.44% | 63 |
|
|
2021
Q4 | $3.89M | Buy |
65,889
+32,207
| +96% | +$1.6M | 0.38% | 60 |
|
|
2021
Q3 | $1.45M | Sell |
33,682
-3,728
| -10% | -$165K | 0.21% | 112 |
|
|
2021
Q2 | $1.46M | Buy |
37,410
+821
| +2% | +$31.9K | 0.22% | 116 |
|
|
2021
Q1 | $1.33M | Sell |
36,589
-496
| -1% | -$17.6K | 0.22% | 110 |
|
|
2020
Q4 | $1.37M | Sell |
37,085
-434
| -1% | -$15.9K | 0.26% | 106 |
|
|
2020
Q3 | $1.31M | Sell |
37,519
-4,879
| -12% | -$171K | 0.33% | 80 |
|
|
2020
Q2 | $1.32M | Sell |
42,398
-684
| -2% | -$23.2K | 0.39% | 75 |
|
|
2020
Q1 | $1.33M | Buy |
43,082
+37,410
| +660% | +$1.27M | 0.55% | 53 |
|
|
2019
Q4 | $211K | Buy |
+5,672
| New | +$202K | 0.07% | 219 |
|
|
2019
Q3 | – | Sell |
-11,157
| Closed | -$459K | – | 192 |
|
|
2019
Q2 | $459K | Sell |
11,157
-957
| -8% | -$38K | 0.18% | 110 |
|
|
2019
Q1 | $488K | Buy |
+12,114
| New | +$485K | 0.2% | 96 |
|
Other funds holding PFE
Ashton Thomas Private Wealth's PFE Position: Q2 2026 in Review
Ashton Thomas Private Wealth increased its Pfizer (PFE) stake by 7.1% in Q2 2026, buying an estimated $98K and bringing the position to 56,570 shares worth $1.36M. The position accounts for 0.03% of the portfolio, ranked #478.
Ashton Thomas Private Wealth first reported a position in PFE in Q1 2019 and has held it in 29 quarters since. The position peaked at $5.69M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ashton Thomas Private Wealth held 56,570 shares of Pfizer worth $1.36M as of Q2 2026.
- Ashton Thomas Private Wealth bought 3,746 Pfizer shares in Q2 2026, an estimated $98K.
- Pfizer made up 0.03% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #478 holding.
- Ashton Thomas Private Wealth first reported a position in Pfizer in Q1 2019 and has held it in 29 quarters since.
- Ashton Thomas Private Wealth's Pfizer position peaked at $5.69M in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.